Pulmonary Hypertension in Pulmonary Langerhans Cell Granulomatosis

Shin, K. H., Lin, M. C., Lai, S. L., & Shiao, G. M. (2002). Pulmonary Lymphangioleiomyomatosis： A Case Report. 胸腔醫學, 17(1), 61-67. https://www.airitilibrary.com/Article/Detail?DocID=10239855-200203-17-1-61-67-a
Yen, P. S., Wan, Y. L., Ng, S. H., Hung, C. F., Tsai, C. C., & Ho, Y. S. (1995). Pulmonary Lymphangioleiomyomatosis: A Case Report. 中華放射線醫學雜誌, 20(1), 89-93. https://www.airitilibrary.com/Article/Detail?DocID=10188940-199503-20-1-89-93-a
Hsu, C. H., Huang, W. C., & Chang, W. T. (2022). Future Perspectives of Pulmonary Hypertension Treatment. Acta Cardiologica Sinica, 38(4), 435-442. https://doi.org/10.6515/ACS.202207_38(4).20220331A
Chiu, Y. W., & Wu, Y. W. (2023). Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management. Acta Cardiologica Sinica, 39(2), 209-212. https://doi.org/10.6515/ACS.202303_39(2).20230208A
Lin, S. W., Hsieh, M. J., & Huang, S. F. (2003). Primary Pulmonary Lymphoma: A Case Report. 胸腔醫學, 18(5), 427-432. https://doi.org/10.29806/TM.200310.0006